Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (271-280 of 463) with videos related to

Pageof 47
Sort By:
Inflammatory Bowel Diseases|July 9, 2018
Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With GolimumabWalter Reinisch, Jean-Frederic Colombel, Peter R Gibson, et al.
The American Journal of Gastroenterology|February 11, 2010
Nutritional status and growth in pediatric Crohn's disease: a population-based studyFrancis Vasseur, Corinne Gower-Rousseau, Gwenola Vernier-Massouille, et al.
Inflammatory Bowel Diseases|August 22, 2025
Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel DiseasesScott R Anderson, Ali Osman, Mohammad Zamani, et al.
The American Journal of Gastroenterology|November 15, 2006
Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control studyEric Lerebours, Corinne Gower-Rousseau, Veronique Merle, et al.
Crohn'S & Colitis 360|August 4, 2020
Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United StatesEdward L Barnes, Laura Raffals, Millie D Long, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug DevelopmentWalter Reinisch, Klaus Gottlieb, Jean-Frederic Colombel, et al.
Gastrointestinal Endoscopy|February 28, 2006
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseasePaul Rutgeerts, Robert H Diamond, Mohan Bala, et al.
Gastro Hep Advances|August 12, 2024
Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 StudiesLaurent Peyrin-Biroulet, Jean-Frederic Colombel, Edouard Louis, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosisAxel Dignass, Rami Eliakim, Fernando Magro, et al.
Inflammatory Bowel Diseases|September 30, 2025
Cross-Sectional Imaging Features Associated With Disease Progression in Crohn's DiseaseSalam P Bachour, Shravya Srinivas-Rao, Nikitha Uma Baskaran, et al.
Pageof 47

Showing results (271-280 of 463) with videos related to

Sort By:
Pageof 47
Inflammatory Bowel Diseases|July 9, 2018
Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With GolimumabWalter Reinisch, Jean-Frederic Colombel, Peter R Gibson, et al.
The American Journal of Gastroenterology|February 11, 2010
Nutritional status and growth in pediatric Crohn's disease: a population-based studyFrancis Vasseur, Corinne Gower-Rousseau, Gwenola Vernier-Massouille, et al.
Inflammatory Bowel Diseases|August 22, 2025
Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel DiseasesScott R Anderson, Ali Osman, Mohammad Zamani, et al.
The American Journal of Gastroenterology|November 15, 2006
Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control studyEric Lerebours, Corinne Gower-Rousseau, Veronique Merle, et al.
Crohn'S & Colitis 360|August 4, 2020
Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United StatesEdward L Barnes, Laura Raffals, Millie D Long, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug DevelopmentWalter Reinisch, Klaus Gottlieb, Jean-Frederic Colombel, et al.
Gastrointestinal Endoscopy|February 28, 2006
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseasePaul Rutgeerts, Robert H Diamond, Mohan Bala, et al.
Gastro Hep Advances|August 12, 2024
Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 StudiesLaurent Peyrin-Biroulet, Jean-Frederic Colombel, Edouard Louis, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosisAxel Dignass, Rami Eliakim, Fernando Magro, et al.
Inflammatory Bowel Diseases|September 30, 2025
Cross-Sectional Imaging Features Associated With Disease Progression in Crohn's DiseaseSalam P Bachour, Shravya Srinivas-Rao, Nikitha Uma Baskaran, et al.
Pageof 47